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Food allergy in general, and CMA in particolar, are an
unique case in which a systematic approach can be
applied even to single cases. As the disease involves not
only the patient, but the whole family and her social
supports, these can be protagonist of the diagnosis itself.
As in any field of medicine, diagnosis starts from the
suspicion. In patients reports for milk allergic reactions,
an accurate medical history can clarify many aspects of
the diagnosis.
If history does not exclude the possibility of a CMA,
in particular in delayed manifestations, in primary set-
ting there is the possibility to take a period of tentative
avoidance of milk, followed by an open re-introduction.
When avoidance coincides with symptom-free periods,
an open reintroduction can be useful to identify the
offending food (if severe symptoms are anticipated, the
procedure should be done under supervision in a medi-
cal facility). This elimination - reintroduction phase
does not eliminate the necessity of challenge tests, but
can give some indication on the possibility of CMA.
We have several methods to evaluate milk sensitiza-
tion. Basically, they are:
- Skin testing, including immediate skin prick test
(SPT), intradermal reactions and atopy patch test (APT)
- The evaluation of serum food -specific IgE using one
of the several methods we have at disposition.
Performance, accuracy, and the diagnostic positioning
of these have been afforded in the DRACMA Guide-
lines. Following these analysis, the following considera-
tions can be formulated:
• Challenge is the best for diagnosing CMA
• If not available, challenge is not necessary in case of:
a. high pre-test probability and SPT+ (classify as
CMA)
b. high pre-test probability and sIgE+ (classify as
CMA)
c. low pre-test probability and SPT- (exclude CMA)
d. low pre-test probability and sIgE- (exclude CMA). •
Challenges remain necessary in all cases of uncertainity
(medium pre-test probability)
• If challenge is necessary out of a research setting,
sensitisation tests may not be necessary.
• Atopy patch test is not useful
• Component-resolved diagnosis may be useful, but
further data are necessary
• Molecular diagnosis may be useful, but more data
are needed.
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